1. Home
  2. WMK vs TRVI Comparison

WMK vs TRVI Comparison

Compare WMK & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

N/A

Current Price

$62.25

Market Cap

1.8B

ML Signal

N/A

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

N/A

Current Price

$11.89

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WMK
TRVI
Founded
1912
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
WMK
TRVI
Price
$62.25
$11.89
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$20.38
AVG Volume (30 Days)
127.7K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.21%
N/A
EPS Growth
5.96
N/A
EPS
2.51
N/A
Revenue
$4,714,573,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.70
N/A
Revenue Growth
0.01
N/A
52 Week Low
$61.27
$4.85
52 Week High
$90.23
$14.39

Technical Indicators

Market Signals
Indicator
WMK
TRVI
Relative Strength Index (RSI) 30.22 52.21
Support Level N/A $10.04
Resistance Level $68.14 $12.11
Average True Range (ATR) 2.29 0.72
MACD -1.04 0.05
Stochastic Oscillator 6.14 47.97

Price Performance

Historical Comparison
WMK
TRVI

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: